Ali Shamseddine

47PUBLICATIONS
61CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Aug 04, 2026
Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies.

|Jul 19, 2026
Tumor Characteristics and Survival Predictors in Patients With Colorectal Cancer: A Lebanese Single-Center Experience.

|May 03, 2026
Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Markers in Resectable Pancreatic Cancer: A Retrospective Longitudinal Study.

|Apr 14, 2026
EGFR Signaling in Colorectal Cancer: Novel Therapeutic Strategies, Predictive Biomarkers, and Counteracting Treatment Resistance.

Noura Abbas, Mohamad Mourad, Hiba Smaily

|Aug 27, 2025
A Review on the Evolving Role of Radiation Therapy in the Treatment of Locally Advanced Rectal Cancer.

Zeinab Dandash, Tala Mobayed, Sally Temraz

|Aug 25, 2025
Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01).

Ali Shamseddine, Noura Abbas, Sally Temraz

Pageof 8

Frequent Collaborators

9 joint publications

Deborah Mukherji

8 joint publications

Noura Abbas

5 joint publications

Sally Temraz

5 joint publications

Laudy Chehade